Czy lek antyarytmiczny może poprawiać odległe rokowanie u chorych z migotaniem przedsionków? Komentarz
##plugins.themes.bootstrap3.article.sidebar##
Opublikowane:
cze 30, 2009
##plugins.themes.bootstrap3.article.main##
Abstrakt
Brak
##plugins.themes.bootstrap3.article.details##
Jak cytować
Trusz-Gluza, M. (2009). Czy lek antyarytmiczny może poprawiać odległe rokowanie u chorych z migotaniem przedsionków?. Medycyna Faktów , 2(2(3), 13-15. Pobrano z https://www.journalsmededu.pl/index.php/jebm/article/view/2659
Numer
Dział
Artykuły
Copyright by Medical Education. All rights reserved.
Bibliografia
1. Kerr C.R., Humphries K.H., Talajic M., Klein G.J., Connolly S.J., Green M., Boone J., Sheldon R., Dorian P., Newman D.: Progression to chronic atrial fibrillation after the initial diagnosis of paroxysmal atrial fibrillation: results from the Canadian Registry of Atrial Fibrillation. Am. Heart. J. 2005; 149: 489-496.
2. Nieuwlaat R., Prins M.H., Le Heuzey J.Y., Vardas P.E., Aliot E., Santini M., Cobbe S.M., Widdershoven J.W., Baur L.H., Lévy S., Crijns H.J.: Prognosis, disease progression, and treatment of atrial fibrillation patients during 1 year: follow-up of the Euro Heart Survey on atrial fibrillation. Eur. Heart J. 2008; 29: 1181-1189.
3. The AFFIRM Investigators. A comparison of rate control and rhythm control In patients with atrial fibrillation. N. Engl. J. Med. 2002; 347: 1825-1833.
4. The AFFIRM Investigators. Relationships between sinus rhythm, treatment, and survival in the AFFIRM study. Circulation 2004; 109: 1509-1513.
5. Hohnloser S.H., Crinjs H.J.G.M., van Eickels M. et al.: Effect of dronedarone on cardiovascular events in atrial fibrillation. N. Engl. J. Med. 2009; 360: 668-678.
6. Singh B.N., Connolly S.J., Crinjs H.J. et al.: Dronedarone for maintenance of sinus rhythm in atrial fibrillation or flutter. N. Engl. J. Med. 2007; 357: 987-999.
7. Kober L., Torp-Pedersen C., McMurray J.J.V. et al.: Increased mortality after dronedarone therapy for severe heart failure. N. Engl. J. Med. 2008; 358: 2678-2687.
8. Hohnloser S.H., Connolly S.J., Crinjs H.J.G.M.: Rationale and design of ATHENA: A placebo-controlled, double-blind, parallel arm trial to assess the efficacy of dronedarone 400 mg bid for the prevention of cardiovascular hospitalization or death from any cause in patients with atrial fibrillation/atrial flutter. J. Cardiovasc. Electrophysiol. 2008; 19: 69-73
9. Nabauer M., Gerth A., Limbourg T. et al. The registry of the german competence network on atrial fibrillation: patients characteristics and initial management. Europace 2009; 11: 423-434.
2. Nieuwlaat R., Prins M.H., Le Heuzey J.Y., Vardas P.E., Aliot E., Santini M., Cobbe S.M., Widdershoven J.W., Baur L.H., Lévy S., Crijns H.J.: Prognosis, disease progression, and treatment of atrial fibrillation patients during 1 year: follow-up of the Euro Heart Survey on atrial fibrillation. Eur. Heart J. 2008; 29: 1181-1189.
3. The AFFIRM Investigators. A comparison of rate control and rhythm control In patients with atrial fibrillation. N. Engl. J. Med. 2002; 347: 1825-1833.
4. The AFFIRM Investigators. Relationships between sinus rhythm, treatment, and survival in the AFFIRM study. Circulation 2004; 109: 1509-1513.
5. Hohnloser S.H., Crinjs H.J.G.M., van Eickels M. et al.: Effect of dronedarone on cardiovascular events in atrial fibrillation. N. Engl. J. Med. 2009; 360: 668-678.
6. Singh B.N., Connolly S.J., Crinjs H.J. et al.: Dronedarone for maintenance of sinus rhythm in atrial fibrillation or flutter. N. Engl. J. Med. 2007; 357: 987-999.
7. Kober L., Torp-Pedersen C., McMurray J.J.V. et al.: Increased mortality after dronedarone therapy for severe heart failure. N. Engl. J. Med. 2008; 358: 2678-2687.
8. Hohnloser S.H., Connolly S.J., Crinjs H.J.G.M.: Rationale and design of ATHENA: A placebo-controlled, double-blind, parallel arm trial to assess the efficacy of dronedarone 400 mg bid for the prevention of cardiovascular hospitalization or death from any cause in patients with atrial fibrillation/atrial flutter. J. Cardiovasc. Electrophysiol. 2008; 19: 69-73
9. Nabauer M., Gerth A., Limbourg T. et al. The registry of the german competence network on atrial fibrillation: patients characteristics and initial management. Europace 2009; 11: 423-434.